Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

CPA: Therapy-resistant Obsessive-Compulsive Patients Respond to Topiramate By Louise Gagnon MONTREAL, QUEBEC -- October 19, 2004 -- Topiramate is effective add-on therapy for some patients with obsessive-compulsive disorder (OCD) who have proved resistant to traditional treatment, according to results of an open-series study presented here at the 54th Canadian Psychiatric Association Annual Meeting. "A sub-group of patients…responded to the addition of topiramate in their therapy," said Michael Van Ameringen, MD, Principal Investigator and Associate Professor of Psychiatry, Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, Ontario, Canada. "We have taken [patients'] OCD from very severe to very minimal by adding topiramate to their therapy. It appears promising." In 5 men and 11 women with a mean duration of illness of 26.2 years –the researchers added topiramate at a mean dose of 253.1 mg/day to selective serotonin reuptake inhibitor (SSRI) monotherapy or SSRI combination therapy over 14 to 26 weeks. At baseline, the mean Clinical Global Improvement (CGI) score was 6.1, indicating patients were regarded as "severely ill". By the end of the treatment period, 68.8% had a significant drop in their CGI score. Specifically, 43.8% of subjects had a score of 2, which indicates they were "much improved," and 25% had a score of 1, which indicates they were "very much improved." Dr. Van Ameringen, who is also Co-director of the Anxiety Disorders Clinic at McMaster University Medical Centre, said that patients with OCD are typically on SSRIs, which produce response rates of 42% to 53%. Dr. Van Ameringen said his team decided to investigate the role of topiramate therapy in OCD as a result of previous basic science research showing promise in this area. "Neuroimaging studies found a deficit in the glutamate system in a group of children who had [OCD]," he explained. "That may say something about the neurobiology of the disorder. It made us explore what agents had an effect on glutamate, such as topiramate." [Presentation title: "Adding Topiramate to an SRI in Treatment-Resistant Obsessive-Compulsive Disorder." Abstract 37] E-mail this page to a friend or colleague! To print, use this version